Biomedical Engineering Reference
In-Depth Information
53. N. Ferrara, R.S. Kerbel, Angiogenesis as a therapeutic target,
Nature
438 (2005)
967-974.
54. D.M. McDonald, P.L. Choyke, Imaging of angiogenesis: From microscope to
clinic,
Nat. Med.
9 (2003) 713-725.
55. V. Ntziachristos, C. Tung, C. Bremer, R. Weissleder, Fluorescence molecular
tomography resolves protease activity in vivo,
Nat. Med.
8 (2002) 757-761.
56. E. Mathiowitz, J.S. Jacob, Y.S. Jong, G.P. Carino, D.E. Chickering, P. Chaturvedi,
C.A. Santos, K. Vijayaraghavan, S. Montgomery, M. Bassett, C. Morrell,
Biologically erodible microspheres as potential oral drug delivery systems,
Nature
386 (1997) 410-414.
57. L.X. Yu, E. Lipka, J.R. Crison, G.L. Amidon, Transport approaches to the bio-
pharmaceutical design of oral drug delivery systems: Prediction of intestinal
absorption,
Adv. Drug Deliv. Rev.
19 (1996) 359-376.
58. I. Lambkin, C. Pinilla, Targeting approaches to oral drug delivery,
Expert Opinion
on Biological Therapy
2 (2002) 67-73.
59. M. Morishita, N.A. Peppas, Is the oral route possible for peptide and protein
drug delivery?
Drug Discov. Today
11 (2006) 905-910.
60. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M.L. Eskew,
J. Mintzes, D. Deaver, N. Lotan, R. Langer, Large porous particles for pulmonary
drug delivery,
Science
276 (1997) 1868-1872.
61. J. Yu, Y.W. Chien, Pulmonary drug delivery: Physiologic and mechanistic
aspects,
CRT
14 (1997) 59.
62. I. Gonda, The ascent of pulmonary drug delivery,
Journal of Pharmaceutical
Sciences
89 (2000) 940-945.
63. H.M. Courrier, N. Butz, T.F. Vandamme, Pulmonary drug delivery systems:
Recent developments and prospects,
CRT
19 (2002) 64.
64. M. Kinoshita, K. Baba, A. Nagayasu, K. Yamabe, T. Shimooka, Y. Takeichi,
M. Azuma, H. Houchi, K. Minakuchi, Improvement of solubility and oral bio-
availability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on
a porous calcium silicate,
Journal of Pharmaceutical Sciences
91 (2002) 362-370.
65. E. Khafagy, M. Morishita, Y. Onuki, K. Takayama, Current challenges in non-
invasive insulin delivery systems: A comparative review, Adv.
Drug Deliv. Rev.
59 (2007) 1521-1546.
66. S. Bisht, G. Feldmann, J.M. Koorstra, M. Mullendore, H. Alvarez, C. Karikari,
M.A. Rudek, C.K. Lee, A. Maitra, A. Maitra, In vivo characterization of a poly-
meric nanoparticle platform with potential oral drug delivery capabilities,
Molecular Cancer Therapeutics
7 (2008) 3878-3888.
67. Y.J. Yamanaka, K.W. Leong, Engineering strategies to enhance nanoparti-
cle-mediated oral delivery,
Journal of Biomaterials Science, Polymer Edition
19
(December 2008) 1549-1570(22).
68. S.P. Vyas, P.N. Gupta, Implication of nanoparticles/microparticles in mucosal
vaccine delivery,
Expert Review of Vaccines
6 (June 2007) 401-418(18).
69. W. Lu, Y. Tan, K. Hu, X. Jiang, Cationic albumin conjugated pegylated nanopar-
ticle with its transcytosis ability and little toxicity against blood-brain barrier,
Int. J. Pharm.
295 (2005) 247-260.
70. N.V.S. Madhav, A.K. Shakya, P. Shakya, K. Singh, Orotransmucosal drug deliv-
ery systems: A review,
J. Controlled Release
140 (2009) 2-11.
71. B. Sarmento, S. Martins, D. Ferreira, E. Souto, Oral insulin delivery by means of
solid lipid nanoparticles,
Int. J. Nanomedicine
2 (2007) 743-749.
Search WWH ::
Custom Search